To study the efficacy and safety of Drotaverine hydrochloride in augmentation of labour
Abstract
Background: Labor is a complex physiological process characterized by painful uterine contractions which bring about the delivery of fetus. Augmentation of labour is common clinical practice and various methods both pharmacological and non -pharmacological are available for the same.
Aims: To assess the efficacy and safety of drotaverine hydrochloride for augmentation of labor.
Materials and Methods: A total of 200 patients in active labor were included in the study after fulfilling the inclusion criteria. The patients were divided into 2 groups by simple randomization method. After a detailed history and examination Group A women received inj. Drotaverine intramuscularly every 2hours for a maximum of three doses. Group B women did not receive injection and served as the control group.
Results: Our study showed a significant reduction in the duration of active phase of first (I) stage of labor (Group A-164mins and Group B- 296mins), with significant improvement in the rate of cervical dilatation (Group A- 2.5cm/hr and Group B- 1.38cm/hr). There were no reports of any serious adverse effects in both mother and the fetus. The most common side effects seen were nausea, vomiting (2%) and headache (1%).
Conclusion: Thus, drotaverine can be safely used as a potent agent for augmentation of labor without any adverse effects on mother and the fetus.
Downloads
References
2. Bindiya Gupta et al. International Journal of Obstetrics and Gynaecology (2008) 100, 240-247.
3. Samuels LA, Christie L, Roberts-Gittens B, et al. The effect of hyoscine butylbromide on the first stage of labour in term pregnancies. BJOG. 2007 Dec;114(12):1542-6. Epub 2007 Sep 27.[pubmed]
4. Rayburn WF. Preinduction cervical ripening: basis and methods of current practice. ObstetGynecolSurv. 2002 Oct;57(10):683-92. DOI:10.1097/01.OGX.0000031755.47006.3C.[pubmed]
5. O'Driscoll K, Jackson RJ, Gallagher JT. Prevention of prolonged labour. Br Med J. 1969 May 24;2(5655):477-80. DOI:10.1136/bmj.2.5655.477.[pubmed]
6. Leroy MJ, Lugnier C, Merezak J, et al. Isolation and characterization of the rolipram-sensitive cyclic AMP-specific phosphodiesterase (type IV PDE) in human term myometrium. Cell Signal. 1994 May;6(4):405-12.[pubmed]
7. Farkas M, Viski S. Relief of pain in childbirth by a new antispasmodic. Ther Hung. 1967;15(4):153-4.[pubmed]
8. Kaur D, Kaur R. Comparison of Drotaverine and Epidosin in first stage of labor. J ObstetGynecol India .2003;53(5):449-52. 58.
9. Batukan AC, Özgün MT, Türkyılmaz C. The effect of valethamate bromide in acceleration of labor: a double-blind, placebo-controlled trial. J Turk Ger Gynecol Assoc.2006;7(3):202-5.
10. Jogi SR. To compare the efficacy of Drotaverine hydrochloride and Valethamate bromide in shortening of the first stage of labour.Int J Reprod Contracept Obstet Gynecol.2015 Aug;4(4):1038-43.
11. Narang M, Shah D, Akhtar H. Efficacy and Safety of Drotaverine Hydrochloride in Children with Recurrent Abdominal Pain: A Randomized Placebo Controlled Trial. Indian Pediatr. 2015 Oct;52(10):847-51.[pubmed]
12. Simhasane et al. Int J of Reproduction Contraception ObstetGynaecol. 2017 Feb;6(2):423-426
13. Palii SB, Akkupalli VL, Maddi S. The Comparative Study of Drotaverine Hydrochloride and Valethamate Bromide in First Stage of Labor.J South Asian Feder Obst Gynae .2013;5(2):52-8.
14. Anju H, Khosla I, Dahiya K. A comparative study of Valethamide Bromide with Drotaverine in normal labor. I obstetgynecol Ind. 2003;53:568-70.
15. Changede PR. Comparision of injection drotaverine and injection valethamate bromide on duration and course of labour. Int J Reproduction Contraception ObstetGynaecol. 2016;5:1836-42.
16. Aziz M. Efficacy of Drotin and Epidosin in Cervical dilatation during Labour-A Comparative Study. International Journal of Advanced Research.2015;3(6):104-18.
17. Sharma JB, Pundir P, Kumar A, et al. Drotaverine hydrochloride vs. valethamate bromide in acceleration of labor. Int J Gynaecol Obstet. 2001 Sep;74(3):255-60.
Copyright (c) 2019 Author (s). Published by Siddharth Health Research and Social Welfare Society
This work is licensed under a Creative Commons Attribution 4.0 International License.
OAI - Open Archives Initiative
Therapoid
